On day 12, downregulation of PDCD11 in p53+/+ tumors led to a growth inhibition rate of ~90%, which was reduced to approximately 60% when p53 was absent, indicating that PDCD11 promoted tumor growth in both p53-dependent and -independent manners. This evidence concerns the gene PDCD11 and neoplasm.